R13	Appositive Attribute:T103 Head:T37
R14	Appositive Attribute:T103 Head:T40
R15	Appositive Attribute:T103 Head:T38
R16	Appositive Attribute:T103 Head:T39
R17	Appositive Attribute:T105 Head:T42
R18	Appositive Attribute:T105 Head:T44
R19	Appositive Attribute:T105 Head:T43
R20	Anaphora Anaphor:T87 Antecedent:T57
R21	Anaphora Anaphor:T89 Antecedent:T58
R22	Anaphora Anaphor:T99 Antecedent:T54
R23	Anaphora Anaphor:T108 Antecedent:T48
R24	Anaphora Anaphor:T108 Antecedent:T49
R25	Anaphora Anaphor:T112 Antecedent:T60
R26	Anaphora Anaphor:T122 Antecedent:T112
R27	Anaphora Anaphor:T131 Antecedent:T64
R28	Anaphora Anaphor:T146 Antecedent:T72
R29	Anaphora Anaphor:T148 Antecedent:T146
T1	Drug_Class 1839 1853	MAO inhibitors
T34	Drug 1990 1999	reserpine
T32	Drug_Class 1920 1945	tricyclic antidepressants
T5	Drug_Class 2033 2039;2052 2075	direct acting sympathomimetics
T36	Drug_Class 2043 2075	indirect acting sympathomimetics
T35	Drug 2019 2028	reserpine
T6	Drug_Class 2119 2139	direct-acting amines
T37	Drug 2141 2152	epinephrine
T38	Drug 2154 2167	isoproterenol
T39	Drug 2169 2182	phenylephrine
T40	Drug 2184 2195	metaraminol
T41	Drug 2244 2253	reserpine
T10	Drug_Class 2269 2291	indirect-acting amines
T42	Drug 2293 2302	ephedrine
T43	Drug 2304 2312	tyramine
T44	Drug_Class 2314 2326	amphetamines
T12	Drug_Class 2453 2475	rauwolfia preparations
T47	Drug 2342 2351	Reserpine
T48	Drug 2383 2392	digitalis
T49	Drug 2397 2406	quinidine
T51	Drug 2496 2505	reserpine
T52	Drug_Class 2517 2540	antihypertensive agents
T53	Drug_Class 1503 1525	rauwolfia preparations
T54	Drug 1587 1601	norepinephrine
T55	Drug 26 35	Reserpine
T56	Drug 48 57	Reserpine
T57	Drug 391 400	Reserpine
T58	Drug 873 882	reserpine
T59	Drug 1254 1263	reserpine
T60	Drug 2709 2718	reserpine
T61	Drug 3137 3146	reserpine
T62	Drug 3674 3683	reserpine
T63	Drug 3908 3917	reserpine
T64	Drug 4068 4077	reserpine
T65	Drug 4446 4455	reserpine
T66	Drug 4565 4574	Reserpine
T67	Drug 4798 4807	reserpine
T68	Drug 4827 4836	Reserpine
T69	Drug 4967 4976	Reserpine
T70	Drug 5118 5127	reserpine
T71	Drug 5163 5172	Reserpine
T72	Drug 5441 5450	reserpine
T73	Drug 5781 5790	reserpine
T74	Drug 5933 5942	reserpine
T75	Drug_Class 1768 1778	medication
T76	Drug 1574 1585	metaraminol
T77	Drug_Class 1963 1979	antihypertensive
T19	Drug_Class 4037 4055	neuroleptic agents
T154	SPAN 1120 1141	hypertensive patients
T82	ZeroArticleNP 0 10	Drug Label
T83	ZeroArticleNP 15 35	drug brand Reserpine
T84	ZeroArticleNP 258 283	electroconvulsive therapy
T85	IndefiniteNP 359 368	a history
T86	DemonstrativeNP 481 495	this condition
T87	DefiniteNP 562 570	The drug
T88	ZeroArticleNP 779 794	drug withdrawal
T89	PersonalPronoun 934 936	it
T90	IndefiniteNP 980 989	a history
T91	PersonalPronoun 1174 1178	they
T92	PersonalPronoun 1325 1327	It
T93	DefiniteNP 1346 1366	the anesthesiologist
T94	DefiniteNP 1379 1390	the patient
T95	DefiniteNP 1426 1448	the overall management
T96	ZeroArticleNP 1393 1404	drug intake
T97	ZeroArticleNP 1503 1525	rauwolfia preparations
T98	ZeroArticleNP 1550 1566	adrenergic drugs
T99	DefiniteNP 1764 1778	the medication
T100	ZeroArticleNP 1839 1853	MAO inhibitors
T101	DefiniteNP 1959 1986	the antihypertensive effect
T102	DefiniteNP 2105 2115	The action
T103	ZeroArticleNP 2119 2139	direct-acting amines
T104	DefiniteNP 2255 2265	The action
T105	ZeroArticleNP 2269 2291	indirect-acting amines
T106	ZeroArticleNP 2453 2475	rauwolfia preparations
T107	IndefiniteNP 2511 2540	other antihypertensive agents
T108	DistributiveNP 2587 2597	each agent
T109	DefiniteNP 2835 2855	the seminal vesicles
T110	IndefiniteNP 2722 2741	an animal tumorigen
T111	IndefiniteNP 2751 2773	an increased incidence
T112	DefiniteNP 2971 2979	the drug
T113	DefiniteNP 3000 3008	the feed
T114	DefiniteNP 3065 3085	the usual human dose
T115	DemonstrativeNP 2923 2937	These findings
T116	DefiniteNP 3087 3107	The breast neoplasms
T117	IndefiniteNP 3248 3270	an increased incidence
T118	DefiniteNP 3304 3314	The extent
T119	IndefiniteNP 3348 3354	a risk
T120	DemonstrativeNP 3324 3338	these findings
T121	DefiniteNP 3528 3535	the use
T122	DefiniteNP 3539 3547	the drug
T123	IndefiniteNP 3489 3497	a factor
T124	IndefiniteNP 3567 3576	a patient
T125	DefiniteNP 3617 3632	The possibility
T126	IndefiniteNP 3636 3653	an increased risk
T127	IndefiniteNP 3770 3797	a few epidemiologic studies
T128	IndefiniteNP 3813 3838	a slightly increased risk
T129	IndefiniteNP 3861 3872	all studies
T130	IndefiniteNP 3919 3932	other studies
T131	DefiniteNP 4230 4238	the drug
T132	IndefiniteNP 4024 4035	other drugs
T133	IndefiniteNP 4181 4195	an association
T134	ZeroArticleNP 4037 4055	neuroleptic agents
T135	DefiniteNP 4348 4370	the available evidence
T136	DemonstrativeNP 4417 4426	this time
T137	DefiniteNP 4498 4518	the seminal vesicles
T138	IndefiniteNP 4428 4442	An association
T139	IndefiniteNP 4677 4698	an embryocidal effect
T140	DefiniteNP 4877 4898	the potential benefit
T141	DefiniteNP 4909 4927	the potential risk
T142	DefiniteNP 4931 4940	the fetus
T143	DefiniteNP 4985 5006	the placental barrier
T144	DefiniteNP 5339 5352	the potential
T145	DefiniteNP 5398 5411	the potential
T146	DefiniteNP 5545 5553	the drug
T147	DefiniteNP 5575 5589	the importance
T148	DefiniteNP 5593 5601	the drug
T149	DefiniteNP 5605 5615	the mother
T150	IndefiniteNP 5470 5480	a decision
T151	DefiniteNP 5770 5777	the use
T152	DefiniteNP 5990 6003	the treatment
T153	IndefiniteNP 5973 5986	a step-2 drug
